Blocking FAK signaling resulted in downregulation of PD-L1, while the use of anti-PD-L1 blocking mAbs inhibited fibroblast migration and invasion, as well as lung fibrosis in humanized SCID mouse model of pulmonary fibrosis [73]. This evidence concerns the gene PTK2 and pulmonary fibrosis.